209 - Real World/Road Rules Challenge: Implementation of Long-Acting ART

Moderator(s)

• 

  Dima Dandachi, MD, MPH (she/her/hers)

  Associate Professor of Medicine
  Medicine - Infectious Diseases
  University of Missouri - Columbia
  Columbia, MO, United States
• 

  Rena Patel, MD, MPH, MPhil (she/her/hers)

  Associate Professor
  University of Alabama at Birmingham

Presentations:

• 10:30 AM - 10:42 AM US ET

  Insurance Changes Are Common and Associated with Delayed Cabotegravir Plus Rilpivirine Injections
  

  Presenting Author: Jennifer M. Davis, MD (she/her/hers) – University of Nebraska Medical Center

  Co-Author: Sara H. Bares, MD – University of Nebraska Medical Center

  Co-Author: Jennifer O'Neill, BSN, RN – University of Nebraska Medical Center

  Co-Author: Elizabeth Lyden, MS – University of Nebraska Medical Center
• 10:42 AM - 10:54 AM US ET

  Discontinuation of Cabotegravir for PrEP: Challenges and Opportunities
  

  Presenting Author: Alexander Kaplan, MD (he/him/his) – Department of Internal Medicine and Pediatrics; David Geffen School of Medicine at UCLA

  Co-Author: Dylan M. Baker, MBBS (he/him/his) – Emory University School of Medicine

  Co-Author: Meredith H. Lora, MD (she/her/hers) – Emory University School of Medicine

  Co-Author: Valeria D. Cantos, MD, FIDSA (she/her/hers) – Emory University School of Medicine
• 10:54 AM - 11:06 AM US ET

  Human Immunodeficiency Virus (HIV) Testing and Evidence of HIV among Real-World Long-Acting Pre-Exposure Prophylaxis (PrEP) Users in a United States Claims Database: Results from the PrEPFACTS Study
  

  Presenting Author: Aimee A. Metzner, PharmD, AAHIVP (she/her/hers) – ViiV Healthcare

  Co-Author: Gabrielle F. Herman, PharmD – ViiV Healthcare

  Co-Author: Catherine Nguyen, MPH – Analysis Group, Inc.

  Co-Author: Raj Desai, PhD – Analysis Group, Inc.

  Co-Author: Shana Walko, PharmD, AAHIVP – ViiV Healthcare

  Co-Author: Dora Martinez, MD, AAHIVS, FAAFP – ViiV Healthcare

  Co-Author: Sherry Shi, Master of Science – Analysis Group

  Co-Author: Leili Young-Xu, n/a – Analysis Group

  Co-Author: Maral DerSarkissian, PhD – Analysis Group, Inc.
• 11:06 AM - 11:18 AM US ET

  PREFER-LA: Improved Adherence and Viral Control in Real-World Study of People with HIV (PWH) in the United States with Adherence Challenges on Oral Antiretroviral Therapy (ART) Switching to Cabotegravir + Rilpivirine Long-Acting (CAB+RPV LA)
  

  Presenting Author: William R. Short, MD (he/him/his) – University of Pennsylvania

  Co-Author: Rebecca Glassman, MD – Westchester Medical Center Health Network

  Co-Author: Christina Harbison, PharmD – Prism Health North Texas

  Co-Author: Mitchell Whitehead, MD – AIDS Healthcare Foundation

  Co-Author: Katie L. Mycock, MChem – Adelphi Real World

  Co-Author: Neil Reynolds, PhD – Adelphi Real World

  Co-Author: Hannah Wallis, MS – Adelphi Real World

  Co-Author: Mona Amet, MPH – Adelphi Real World

  Co-Author: Ann Linskey, PharmD, AAHIVP – ViiV Healthcare

  Co-Author: Jimena Patarroyo, PharmD, AAHIVP – ViiV Healthcare

  Co-Author: Deanna Merrill, PharmD, MBA, AAHIVP – ViiV Healthcare

  Co-Author: Edgar T. Overton, MD – ViiV Healthcare

  Co-Author: Cindy Garris, MS (she/her/hers) – ViiV Healthcare

  Co-Author: Andrew P. Brogan, PhD – ViiV Healthcare
• 11:18 AM - 11:30 AM US ET

  Community-based PrEP delivery in urban US settings: the first US mobile retail pharmacy
  

  Presenting Author: Sheela Shenoi, MD MPH (she/her/hers) – Yale University

  Co-Author: Angela Di Paola, PhD – Yale University

  Co-Author: Adati Tarfa, PharmD, PhD (she/her/hers) – Yale University

  Co-Author: Cynthia Frank, PhD, RN – Yale School of Medicine

  Co-Author: Alysse Schultheis, MA – Yale School of Medicine

  Co-Author: Ralph P. Brooks, MS – Yale School of Medicine - AIDS Program

  Co-Author: Sandra Ann Springer, MD – Yale University
• 11:30 AM - 11:43 AM US ET

  Acceptability, Feasibility and Appropriateness of the Mobile Outreach Retention and Engagement (MORE) Program and Home Long-Acting Cabotegravir/Rilpivirine (CAB+RPV LA) Injections for People with HIV (PWH) Experiencing Adherence Challenges at Whitman-Walker Health in Washington D.C.
  

  Presenting Author: Megan Dieterich, MPH, MMSc, PA-C – Whitman-Walker Institute

  Co-Author: Rupa Patel

  Co-Author: Maria Rybicki-Newman, PhD – Whitman-Walker Institute

  Co-Author: Keyerra Richardson, MPH – Whitman-Walker Institute

  Co-Author: Eleanor Sarkodie, MPH – The Institute for Health Research & Policy at Whitman-Walker

  Co-Author: Janelle Schrag, MPH – Whitman-Walker Institute

  Co-Author: Robert Bangert, LICSW – Whitman-Walker Health

  Co-Author: Chris Kubaska, BA – Whitman-Walker Health

  Co-Author: Lauren Brittingham, BA – Whitman-Walker Health

  Co-Author: Meghan Davies, MPH – Whitman-Walker Health

  Co-Author: Namrata Shah, MD – Whitman-Walker Institute

  Co-Author: H. Jonathon Rendina, PhD – Whitman-Walker Institute